title: Renal cholesterol microembolism: is steroid therapy effective?
authors.forename: N
authors.initials: N
authors.lastname: Stabellini
authors.forename: E
authors.initials: E
authors.lastname: Rizzioli
authors.forename: M R
authors.initials: MR
authors.lastname: Trapassi
authors.forename: F
authors.initials: F
authors.lastname: Fabbian
authors.forename: C
authors.initials: C
authors.lastname: Catalano
authors.forename: P
authors.initials: P
authors.lastname: Gilli
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology*; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D003328:Coronary Thrombosis / Q000188:drug therapy*; D003348:Cortisone / Q000627:therapeutic use*; D003490:Cyanosis; D017700:Embolism, Cholesterol / Q000175:diagnosis* / Q000188:drug therapy; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D007668:Kidney / Q000473:pathology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010146:Pain; D011241:Prednisone / Q000627:therapeutic use; D012079:Renal Circulation; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D014665:Vasodilator Agents; D006493:Heparin; D003348:Cortisone; D011241:Prednisone; D008775:Methylprednisolone